NovoCure (NVCR) Interest Expenses (2014 - 2022)

NovoCure's Interest Expenses history runs 9 years deep, the most recent figure standing at $2.2 million for Q2 2022.

• In Q2 2022, Interest Expenses rose 137.02% year-over-year to $2.2 million; the TTM figure through Mar 2023 stood at $2.2 million (down 67.26% YoY), while the FY2021 annual figure was $7.7 million, down 37.05% from the prior year.
• Interest Expenses came in at $2.2 million for Q2 2022 at NovoCure, up from $1.7 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $4.9 million in Q1 2018 to a low of $940000.0 in Q2 2021.
• A 5-year average of $2.5 million and a median of $2.4 million in 2018 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses slumped 64.08% in 2021 and soared 137.02% in 2022, its largest moves.
• NovoCure's Interest Expenses stood at $2.2 million in 2018, then fell by 19.21% to $1.7 million in 2019, then soared by 87.22% to $3.3 million in 2020, then plunged by 33.43% to $2.2 million in 2021, then advanced by 2.44% to $2.2 million in 2022.
• According to Business Quant data, Interest Expenses over the past three periods registered $2.2 million, $1.7 million, and $2.2 million for Q2 2022, Q1 2022, and Q4 2021 respectively.

Peer Comparison